Prevention of anxiety and depression during induction chemotherapy in previously untreated patients newly diagnosed with acute leukemia Mental and Behavioural Disorders
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Newly diagnosed with acute leukemia, including acute myeloid leukemia and acute lymphocytic leukemia 2. No relevant previous treatment 3. Aged 18 years and over 4. Normal cognition and comprehension 5. Karnofsky Performance Status >60
Exclusion criteria
Exclusion criteria: 1. Aggravation in related symptoms, such as severe infection, bleeding, or anemia 2. Complicated with other neoplastic diagnoses 3. In a critical condition 4. Accompanied eye-related diseases 5. Refused participation or participating in other studies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Anxiety is measured using State Anxiety Inventory at baseline and post-intervention (2 weeks) 2. Depression is measured using the Center for Epidemiological Studies Depression Scale at baseline and post-intervention (2 weeks) | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life is measured using The Functional Assessment of Cancer Therapy-Leukemia Questionnaire at baseline and post-intervention (2 weeks). | — |
Countries
China